These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37209794)

  • 1. Prevalence and Prognostic Implications of Amyloidosis in Valvular Heart Disease.
    Hussain B; Duhan S; Mahmood A; Al-Alawi L; Vargas C; Khan S; Ali Z; Waqar F; Alfonso C; Cuevas C; Alexander T
    Curr Probl Cardiol; 2023 Oct; 48(10):101811. PubMed ID: 37209794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Valvular Heart Disease on Clinical Outcomes in Sarcoidosis.
    Hussain B; Markson F; Mamas MA; Alraies C; Aggarwal V; Kumar G; Desai R; Paul TK
    Curr Probl Cardiol; 2023 Oct; 48(10):101866. PubMed ID: 37301487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease.
    Lv J; Xu H; Ye Y; Li Z; Wang W; Zhang B; Zhao Q; Zhang H; Zhao Z; Liu Q; Wang B; Duan Z; Yu Z; Guo S; Zhao Y; Gao R; Ge J; Wu Y;
    ESC Heart Fail; 2024 Feb; 11(1):349-365. PubMed ID: 38012105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of hospitalized patients with valvular heart disease: Experience of a tertiary center.
    Esteves AF; Brito D; Rigueira J; Ricardo I; Pires R; Pedro MM; Veiga F; Pinto F
    Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):991-998. PubMed ID: 30554887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020.
    Tan MC; Yeo YH; San BJ; Suleiman A; Lee JZ; Chatterjee A; Sell-Dottin KA; Sweeney JP; Fortuin FD; Lee KS
    J Am Heart Assoc; 2024 Apr; 13(8):e030895. PubMed ID: 38587138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis.
    Banerjee A; Allan V; Denaxas S; Shah A; Kotecha D; Lambiase PD; Joseph J; Lund LH; Hemingway H
    Europace; 2019 Dec; 21(12):1776-1784. PubMed ID: 31408153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China.
    Shu C; Chen S; Qin T; Fu Z; Sun T; Xie M; Zhang L; Dong N; Yin P
    Sci Rep; 2016 Jun; 6():27253. PubMed ID: 27250873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
    Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
    BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes.
    Abbott KC; Hshieh P; Cruess D; Agodoa LY; Welch PG; Taylor AJ; Yuan CM
    Clin Nephrol; 2003 Feb; 59(2):79-87. PubMed ID: 12608550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review regarding the article 'Prevalence of Valvular Heart Disease in Cardiac Amyloidosis and Impact on Survival'.
    Fan Q; Zhang Y; Ling Y
    Curr Probl Cardiol; 2024 Jul; 49(7):102574. PubMed ID: 38653443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.
    Rezzoug N; Vaes B; de Meester C; Degryse J; Van Pottelbergh G; Mathei C; Adriaensen W; Pasquet A; Vanoverschelde JL
    BMC Cardiovasc Disord; 2016 Jan; 16():7. PubMed ID: 26754575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of people with valvular heart disease in a large, English community-based cohort study.
    Taylor CJ; Ordóñez-Mena JM; Jones NR; Roalfe AK; Myerson SG; Prendergast BD; Hobbs FR
    Heart; 2021 Aug; 107(16):1336-1343. PubMed ID: 34031157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival.
    Minga I; Kwak E; Hussain K; Wathen L; Gaznabi S; Singh L; Macrinici V; Wang CH; Singulane C; Addetia K; Sarswat N; Slivnick J; Pursnani A
    Curr Probl Cardiol; 2024 Apr; 49(4):102417. PubMed ID: 38280494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
    J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication.
    Kurmann RD; El-Am EA; Radwan YA; Sandhu AS; Crowson CS; Matteson EL; Warrington KJ; Mankad R; Makol A
    J Rheumatol; 2021 Jul; 48(7):1047-1052. PubMed ID: 33452164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019.
    Izumi C; Matsuyama R; Asaoka M; Iwasaki K; Takeshima T; Murphy S; Teng L; Igarashi A
    J Cardiol; 2023 Jul; 82(1):29-34. PubMed ID: 36963659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.